Literature DB >> 135420

[Animal experiment studies on parenteral utilization of maltose].

H Förster, I Hoos.   

Abstract

The utilisation of parenterally administered maltose was investigated in the anaesthetized rat, and in rats fixed in metabolic cages. Additionally, the metabolism of maltose was measured with the isolated perfused rat liver. During intravenous infusion of 0.3 g, 0.6 g or 1.2 g maltose (corresponding to 0.9 g, 1.8 g or 3.6 g/kg bodyweight) per hour a steady-state for maltose in blood was attained. Blood glucose concentration rose during the maltose infusions. The utilisation of parenterally administered maltose was established by a high rate of glycogen storage in the liver and by a decrease in concentration of free fatty acids in serum. During the 72 hour infusion of maltose at a rate of 0.23 g/hour (corresponding to 0.70 g/kg bodyweight) a constant blood maltose concentration of 60 mg/100 ml was measured. Simultaneously, the blood glucose concentration increased. The excretion of maltose and of glucose was approximately 5% of the total amount administered intravenously. The nitrogen sparing effect of maltose was equal to that of glucose (or glucose substitutes). In the streptozotocindiabetic rats, the renal excretion of maltose and glucose was 20-30% of the total amount. Moreover, blood glucose concentration was elevated significantly during maltose infusion. In the isolated perfused rat liver maltose hydrolysis was established. However, the glucose obtained by this hydrolysis was not metabolized by the isolated organ as was observed for glucose. On the other hand, the glucose substitutes (fructose, xylitol, sorbitol) are also partially transformed to glucose by the isolated liver. These substances, however, were additionally utilized by this organ in other ways. On the basis of these results it is concluded that maltose is metabolized following its intravenous application. Therefore, maltose should have advantages compared to glucose because of the lower osmotic pressure. The metabolism of maltose, however, is similar to that of glucose. The advantages of the glucose substitutes (fructose, sorbitol, xylitol) are not shared by maltose.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 135420     DOI: 10.1007/bf02022004

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  12 in total

1.  THE DIGESTION AND ABSORPTION OF MALTOSE AND TREHALOSE BY THE INTACT RAT.

Authors:  A DAHLQVIST; D L THOMSON
Journal:  Acta Physiol Scand       Date:  1963 Sep-Oct

2.  A fluorometric assay of alpha-glucosidase and its application in the study of Pompe's disease.

Authors:  I S Salafsky; H L Nadler
Journal:  J Lab Clin Med       Date:  1973-03

3.  [Metabolic studies on the use of stroma-free hemoglobin solutions as oxygen carriers].

Authors:  H Förster; I Hoos
Journal:  Infusionstherapie       Date:  1974-08

4.  [Metabolic investigations during and after infusions of glucose and other sugars (author's transl)].

Authors:  H Förster; D Zagel
Journal:  Dtsch Med Wochenschr       Date:  1974-06-14       Impact factor: 0.628

5.  [Biochemical considerations of the use of carbohydrates in parenteral feeding].

Authors:  H Förster; H Hoffmann
Journal:  Infusionstherapie       Date:  1974-04

6.  Metabolism of uniformly labeled [14C]maltotriose in the rat.

Authors:  E Weser; M Friedman; M H Sleisenger
Journal:  Biochim Biophys Acta       Date:  1967-02-07

7.  Metabolism of circulating disaccharides in man and the rat.

Authors:  E Weser; M H Sleisenger
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

8.  The suitability of maltose for parenteral nutrion.

Authors:  H Förster; I Hoos
Journal:  Eur J Intensive Care Med       Date:  1975-11

9.  The metabolism of circulating maltose in man.

Authors:  J M Young; E Weser
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

Authors:  H G HERS
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

View more
  1 in total

1.  [Tests with human volunteers on parenteral utilization of maltose].

Authors:  H Förster; I Hoos; S Boecker
Journal:  Z Ernahrungswiss       Date:  1976-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.